Skip to content
Open access

Comparison of Metabolic Dysfunction‐Associated Steatotic Liver Disease Between Individuals With Werner Syndrome and Those With Insulin‐Resistant Type 2 Diabetes: Hepatic Steatosis and Fibrosis Indices

Oct 2026 · Geriatrics & Gerontology International · Vol 26 · 0 citations · 22 references
Medicine

Abstract

This study compared metabolic dysfunction‐associated steatotic liver disease (MASLD) in individuals with Werner syndrome (WS) and individuals with insulin‐resistant type 2 diabetes (T2D). It also examined the association with imaging findings of MASLD in individuals with WS, clarified the characteristics of MASLD that accompany WS, and identified useful indices for its diagnosis in addition to imaging.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.